立即打开
世界卫生组织称,猴痘病毒可以通过性接触传播,但猴痘并非性传播疾病。这是什么意思?

世界卫生组织称,猴痘病毒可以通过性接触传播,但猴痘并非性传播疾病。这是什么意思?

Andrew Marquardt 2022-05-29
美国疾病控制与预防中心表示,猴痘病毒通过皮肤创口、呼吸道或眼、鼻、口等进入人体。

过去三周,北美和欧洲的猴痘病例急剧增加。世界卫生组织(World Health Organization)称,致命的猴痘病毒主要通过男性之间的性接触传播。

猴痘病毒通过与感染者、感染动物或被污染材料密切接触发生人际传播。美国疾病控制与预防中心(CDC)表示,病毒通过皮肤创口、呼吸道或眼、鼻、口等进入人体。

世界卫生组织的官员指出,猴痘病毒本身并非性传播感染疾病,也不会通过精子和阴道分泌物传播。但感染者的密切接触者被认为有较高的感染风险。

世界卫生组织的艾滋病毒、肝炎和其他性传播感染疾病顾问安迪·西尔告诉美国消费者新闻与商业频道(CNBC):“许多疾病可以通过性接触传播。在性接触过程中可能会咳嗽或感冒,但这并不意味着它是一种性传播疾病。”

据《华尔街日报》(Wall Street Journal)报道,为了应对全球急剧增多的猴痘病例,丹麦疫苗制造商Bavarian Nordic正在增加天花疫苗产量,以帮助政府应对愈演愈烈的猴痘疫情。

截至5月21日,世界卫生组织表示包括美国、澳大利亚、德国和西班牙在内,全球12个国家已经报告了92例确诊病例和28例疑似病例。

美国疾病控制与预防中心在上周告诉《财富》杂志,卫生官员正在监测六例猴痘疑似病例,这六人都曾经乘坐5月3日至4日从尼日利亚飞往伦敦的一架航班,坐在他们附近的一名乘客感染了猴痘病毒。

猴痘是一种与天花和牛痘相关的罕见病,会引起发烧、肌肉疼痛和病变等症状。美国疾病控制与预防中心称,猴痘从感染到出现症状的潜伏期通常为一两周,但也可能在5天至21天之间。

美国疾病控制与预防中心指出,猴痘在非洲较为常见,感染者的死亡率高达10%。这种疾病通常会持续两周至四周。

虽然目前没有专门针对猴痘的疫苗,但天花疫苗对猴痘感染的保护力至少达到85%,包括Bavarian Nordic提供的疫苗。

美国疾病控制与预防中心称,Bavarian Nordic的天花疫苗,在美国被称为“Jynneos”疫苗,是目前在美国获得许可的两种预防天花的疫苗之一。它是美国唯一一款获得特别许可的预防猴痘的疫苗。

Bavarian Nordic公司的首席执行官保罗·卓别林对《华尔街日报》表示,公司最近几周接到了“几十个国家”有关Jynneos疫苗的咨询电话。这种疫苗在欧洲和加拿大分别被称为Imvanex和Imvamune。

卓别林告诉《华尔街日报》,目前疫苗供应量有限,但公司将在未来几周和几个月持续增加产量。

他说:“经过讨论,我们有信心在相对较短的时间内满足需求。”

美国总统乔·拜登在5月22日对记者表示,美国及其他国家不断增加的病例,应该引起美国民众的关注。

他对记者表示:“他们还没有告诉我疫情的严重程度,但所有人都应该关注猴痘病毒。如果病毒扩散,就将造成严重后果。”

但在5月23日,拜登改口称美国有“疫苗应对猴痘病毒。”

他表示:“我并不认为猴痘病毒会发展到与新冠疫情一样的严重程度。”

据卓别林表示,美国和加拿大是仅有的两个有足够Bavarian Nordic疫苗库存的国家。美国疾病控制与预防中心称,美国有足够的天花疫苗,一旦爆发猴痘疫情,足以为所有美国人接种疫苗。(财富中文网)

译者:刘进龙

审校:汪皓

过去三周,北美和欧洲的猴痘病例急剧增加。世界卫生组织(World Health Organization)称,致命的猴痘病毒主要通过男性之间的性接触传播。

猴痘病毒通过与感染者、感染动物或被污染材料密切接触发生人际传播。美国疾病控制与预防中心(CDC)表示,病毒通过皮肤创口、呼吸道或眼、鼻、口等进入人体。

世界卫生组织的官员指出,猴痘病毒本身并非性传播感染疾病,也不会通过精子和阴道分泌物传播。但感染者的密切接触者被认为有较高的感染风险。

世界卫生组织的艾滋病毒、肝炎和其他性传播感染疾病顾问安迪·西尔告诉美国消费者新闻与商业频道(CNBC):“许多疾病可以通过性接触传播。在性接触过程中可能会咳嗽或感冒,但这并不意味着它是一种性传播疾病。”

据《华尔街日报》(Wall Street Journal)报道,为了应对全球急剧增多的猴痘病例,丹麦疫苗制造商Bavarian Nordic正在增加天花疫苗产量,以帮助政府应对愈演愈烈的猴痘疫情。

截至5月21日,世界卫生组织表示包括美国、澳大利亚、德国和西班牙在内,全球12个国家已经报告了92例确诊病例和28例疑似病例。

美国疾病控制与预防中心在上周告诉《财富》杂志,卫生官员正在监测六例猴痘疑似病例,这六人都曾经乘坐5月3日至4日从尼日利亚飞往伦敦的一架航班,坐在他们附近的一名乘客感染了猴痘病毒。

猴痘是一种与天花和牛痘相关的罕见病,会引起发烧、肌肉疼痛和病变等症状。美国疾病控制与预防中心称,猴痘从感染到出现症状的潜伏期通常为一两周,但也可能在5天至21天之间。

美国疾病控制与预防中心指出,猴痘在非洲较为常见,感染者的死亡率高达10%。这种疾病通常会持续两周至四周。

虽然目前没有专门针对猴痘的疫苗,但天花疫苗对猴痘感染的保护力至少达到85%,包括Bavarian Nordic提供的疫苗。

美国疾病控制与预防中心称,Bavarian Nordic的天花疫苗,在美国被称为“Jynneos”疫苗,是目前在美国获得许可的两种预防天花的疫苗之一。它是美国唯一一款获得特别许可的预防猴痘的疫苗。

Bavarian Nordic公司的首席执行官保罗·卓别林对《华尔街日报》表示,公司最近几周接到了“几十个国家”有关Jynneos疫苗的咨询电话。这种疫苗在欧洲和加拿大分别被称为Imvanex和Imvamune。

卓别林告诉《华尔街日报》,目前疫苗供应量有限,但公司将在未来几周和几个月持续增加产量。

他说:“经过讨论,我们有信心在相对较短的时间内满足需求。”

美国总统乔·拜登在5月22日对记者表示,美国及其他国家不断增加的病例,应该引起美国民众的关注。

他对记者表示:“他们还没有告诉我疫情的严重程度,但所有人都应该关注猴痘病毒。如果病毒扩散,就将造成严重后果。”

但在5月23日,拜登改口称美国有“疫苗应对猴痘病毒。”

他表示:“我并不认为猴痘病毒会发展到与新冠疫情一样的严重程度。”

据卓别林表示,美国和加拿大是仅有的两个有足够Bavarian Nordic疫苗库存的国家。美国疾病控制与预防中心称,美国有足够的天花疫苗,一旦爆发猴痘疫情,足以为所有美国人接种疫苗。(财富中文网)

译者:刘进龙

审校:汪皓

Monkeypox, a potentially lethal disease responsible for an alarming rise in cases in North America and Europe over the past three weeks, is primarily spreading through sex between men, according to the World Health Organization.

The disease is spread through close contact with infected people, animals, or materials that are contaminated with the virus. It enters the body through broken skin, the respiratory tract or through the eyes, nose or mouth, according to the CDC.

The virus is not considered a sexually transmitted infection, or spread through semen and vaginal fluids, WHO officials noted. Anyone in close contact with a person who has the virus is considered at high risk of infection, however.

“Many diseases can be spread through sexual contact. You could get a cough or a cold through sexual contact, but it doesn’t mean that it’s a sexually transmitted disease,” Andy Seale, an adviser to the WHO about HIV, hepatitis and other sexually transmitted infections, told CNBC.

In response to the rising number of monkeypox cases worldwide, Bavarian Nordic, a Danish vaccine manufacturer, is ramping up production of its smallpox vaccine to help governments fight the growing outbreak, according to a Wall Street Journal report.

As of May 21, 92 confirmed cases and 28 suspected cases of monkeypox have been reported to the WHO from 12 countries, including the U.S., Australia, Germany, and Spain.

In the U.S., Centers for Disease Control and Prevention officials told Fortune last week that health officials are monitoring six people for suspected cases of monkeypox, all of whom sat next to a person on a May 3-4 flight from Nigeria to London who eventually developed the virus.

Monkeypox is a rare disease related to smallpox and cowpox that causes fever, muscle aches, and lesions. The incubation period, or time between exposure and the onset of symptoms, is usually a week or two but can range from five to 21 days, according to the CDC.

In Africa, where the disease is typically found, monkeypox has proven deadly in as many as 10% of infected persons, the CDC notes. The illness typically lasts anywhere between two and four weeks.

While there is no vaccine that specifically targets monkeypox, smallpox vaccines including the one offered by Bavarian Nordic, can protect against monkeypox infections by at least 85%, according to the CDC.

Known as Jynneos in the U.S., the Bavarian Nordic smallpox vaccine is one of two vaccines currently licensed in the U.S. to prevent smallpox, according to the CDC. It is the only vaccine that the U.S. specifically licenses to prevent monkeypox, however.

Speaking to the Wall Street Journal, Bavarian Nordic CEO Paul Chaplin said the company has received calls from “dozens of countries” in recent weeks asking about Jynneos, which is known as Imvanex in Europe and Imvamune in Canada.

Supply of the vaccine is currently limited, but the company will be increasing its manufacturing in the weeks and months ahead, Chaplin told the Wall Street Journal.

“We feel confident based on discussions that we’ll be able to meet the demand in a relatively short period of time,” Chaplin said.

Speaking to reporters on May 22, President Joe Biden said the public should be concerned about the rising number of cases in the U.S. and abroad.

“They haven’t told me the level of exposure yet, but it is something that everybody should be concerned about,” Biden told reporters. “It is a concern in that if it were to spread, it would be consequential.”

On May 23, Biden backtracked those comments, saying the country has “vaccines to take care of it.”

"I just don't think it rises to the level of the kind of concern that existed with COVID-19,” Biden said.

According to Chaplin, the U.S. and Canada are the only two countries that have meaningful stockpiles of the Bavarian Nordic vaccines. The CDC says the U.S. has access to enough doses of smallpox vaccine to vaccinate every person in the United States if an outbreak were to occur.

热读文章
热门视频
扫描二维码下载财富APP